Showing results (471-480 of 3,180) with videos related to
Sort By:
Pageof 318
Molecular Cancer Research : MCR|April 9, 2025
The Bridging Role of Schwann Cells in the Interaction between Tumors and the Nervous System: A Potential Target for Cancer TherapyYonghui Zhang, Ye Yuan, Ying Wang, et al.Molecular Cancer Research : MCR|April 4, 2025
VAV2 drives EGFR-mediated Rac1 responses in prostate cancerMartin J Baker, Suli Zhang, Daniel Zhang, et al.Molecular Cancer Research : MCR|May 16, 2025
Mitochondrial HSP90 paralog TRAP1 deletion drives glutamine addiction in tumor cells via destablization of the Cys/Glu antiporter SLC7A11/xCTAbhinav Joshi, Li Dai, Marisa Maisiak, et al.Molecular Cancer Research : MCR|October 14, 2025
Loss of Regulator of G Protein Signaling 11 Promotes Protumorigenic Features in Pancreatic CancerTejinder Kaur, Debasis Nayak, Arnav Joshi, et al.Molecular Cancer Research : MCR|August 4, 2025
Myeloid-Derived Suppressor Cells: Orchestrators of Tumor Immune Evasion and Therapeutic VulnerabilitiesZiyu Wang, Xiaoping Du, Xiangxue Xing, et al.Molecular Cancer Research : MCR|September 17, 2013
Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9Hui Zhang, Yiqian Chen, Fiona M Keane, et al.Molecular Cancer Research : MCR|September 19, 2013
miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinomaZhaojian Liu, Elizabeth Gersbach, Xiyu Zhang, et al.Molecular Cancer Research : MCR|July 24, 2014
DRO1 inactivation drives colorectal carcinogenesis in ApcMin/+ miceJessica I Grill, Jens Neumann, Andreas Herbst, et al.Molecular Cancer Research : MCR|July 26, 2014
Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cellsArishya Sharma, Allison J Janocha, Brian T Hill, et al.Molecular Cancer Research : MCR|July 27, 2014
Unbiased proteomic and transcript analyses reveal that stathmin-1 silencing inhibits colorectal cancer metastasis and sensitizes to 5-fluorouracil treatmentWei Wu, Xing Fei Tan, Hwee Tong Tan, et al.Pageof 318